752
D. K. O’Dell, K. M. Nicholas / Tetrahedron 59 (2003) 747–754
(30), 225 (Mþ –NO2, 100), 194 (20), 166 (15), 138 (6);
HRMS (ESI) calcd for C11H10NO5Na (MþNa) 294.0145;
found: 294.0103.
(35 mg, 0.10 mmol) were placed in a glass-lined, stainless
steel 15 mL Parr reaction vessel with benzene (10 mL). The
vessel was flushed thrice with CO (fume hood) and charged
to 800 psi. The mixture was heated to 1508C while stirring
for 18 h. After cooling and venting the CO (fume hood), the
resulting dark brown solution was filtered to remove
insoluble material, the filtrate concentrated, and then
chromatographed on silica gel with a gradient elution of
Et2O/hexanes (1:5–9:1) giving the following compounds:
4.1.5. Methyl 2-[hydroxy(6-nitro-1,3-benzodioxol-5-
2-Nitropiperonal
yl)methyl]acrylate
(6).
(3.00 g,
15.4 mmol) was dissolved in methyl acrylate (20 mL),
DABCO (1.72 g, 15.4 mmol) was added slowly over 5 min
upon which the mixture became a dark orange-red. The
mixture was stirred at room temperature for 7 days; after
one day a yellow precipitate formed. After the above
described workup, chromatography on silica gel using a
gradient elution with Et2O/hexanes (20–50% Et2O) gave
4.10 g (95%) of 6, Rf¼0.2 (1:1, Et2O/hexanes); mp 122–
123.58C; IR (KBr) 3494, 1712, 1637, 1531, 1482, 1343,
4.3.1. Methyl 5-chloro-1-formylindoline-3-carboxylate
(13).37 30 mg (13%); Rf¼0.13 (Et2O/hexanes, 3:1); IR
(KBr) 3452, 2975, 1738, 1684, 1491, 1367, 1321,
;
819 cm21 1H NMR (300 MHz; CD3CN) 3.72 (s, 3H),
4.05–4.15 (m, 1H), 4.24–4.47 (m, 2H), 7.26 (m, 2H), 7.41
(m, 0.7H), 7.93 (d, J¼8.7 Hz, 0.3H, minor isomer), 8.42 (s,
0.3H, minor), 8.86 (s, 0.7H, major); 13C NMR (75.45 MHz;
CD3CN) 45.1, 45.6, 48.1, 50.2, 53.2, 111.8, 117.6, 126.0,
126.3, 127.1, 128.8, 129.3, 131.7, 158.5, 160.5, 171.7; MS
(EI) 241 (Mþ, 15), 239 (50), 211 (16), 180 (31), 154 (32),
152 (100), 117 (78), 89 (14); Anal. calcd for C11H10ClNO3:
C, 55.13; H, 4.21; N, 5.84. Found: C, 54.91; H, 4.33; N,
5.54.
1
1256, 1030, 879, 822 cm21; H NMR (300 MHz; CD3CN)
3.71 (s, 3H), 4.02 (br s, 1H), 5.67 (d, J¼0.9 Hz, 1H), 6.15
(m, 3H), 7.17 (s, 1H), 7.49 (s, 1H); 13C NMR (75.45 MHz;
CD3CN) 52.6, 67.3, 104.5, 105.7, 108.2, 125.5, 135.2,
142.2, 143.4, 148.2, 153.0, 166.8; MS (EI) 235 (Mþ –NO2,
20), 221 (32), 204 (76), 188 (64), 176 (100), 160 (26), 148
(18), 135 (9), 120 (7), 104 (4), 77 (3), 53 (8); HRMS (ESI)
calcd for C12H11NO7Na (MþNa) 304.0433; found:
304.0412; Anal. calc: C 51.25, H 3.94, N 4.98; found: C
51.25, H 3.99, N 4.86.
4.3.2. Methyl 5-chloro-1H-indole-3-carboxylate (14).
23 mg (11%); mp 110–1128C; Rf¼0.18 (Et2O/hexanes,
1:1); IR (KBr) 3250, 1680, 1524, 1443; 1H NMR (300 MHz;
CD3CN) 3.87 (s, 3H), 7.23 (dd, J¼8.8, 2.1 Hz, 1H), 7.51 (d,
J¼8.7 Hz, 1H), 7.97 (s, 1H), 8.07 (d, J¼2.1 Hz, 1H), 10.06
(br s, 1H); 13C NMR (75.45 MHz; CD3CN) 51.4, 114.3,
120.8, 123.6, 133.8, 165.4; MS (EI) 211 (15), 209 (50),
178 (100), 150 (24), 123 (8); HRMS (ESI) calcd for
C10H8ClNO2Na (MþNa) 232.0141; found: 232.0080.
4.2. Cyclization of Baylis–Hillman adduct 4
Compound 4 (0.20 g, 0.84 mmol) and Fp2 (30 mg,
0.085 mmol) were placed in a glass-lined, stainless steel
Parr reaction vessel with dioxane (10 mL). The vessel was
flushed three times with CO (fume hood) and charged to
800 psi. The mixture was the heated to 1508C with stirring
for 14 h. After cooling and venting of CO (fume hood), the
resulting brown solution was filtered to remove insoluble
material, concentrated and then chromatographed on silica
gel with a gradient elution of Et2O/hexanes (1:5–9:1) to
give the following compounds:
4.3.3. Methyl 6-chloroquinoline-3-carboxylate (15). 8 mg
(4%); Rf¼0.2 (Et2O/hexanes, 1:3), mp 170–1728C; IR
(KBr) 3066, 2950, 1722, 1491, 1436, 1336, 1267, 1097,
1
819 cm21. H NMR (300 MHz; d6-acetone) 4.00 (s, 3H),
7.89 (dd, J¼9.0, 2.4 Hz, 1H), 8.12 (d, J¼9.0 Hz, 1H), 8.24
(d, J¼2.1 Hz, 1H), 8.93 (d, J¼1.5 Hz, 1H), 9.35 (d, J¼
2.1 Hz, 1H); 13C NMR (75.45 MHz; CDCl3) 52.7, 132.7,
127.5, 130.9, 132.7, 133.3, 137.7, 148.0, 150.0, 165.3; MS
(EI) 221 (Mþ, 100), 190 (95), 162 (70), 127 (27), 99 (16), 74
(5); HRMS (ESI) calcd for C11H8ClNO2Na (MþNa)
244.0141; found: 244.0092.
4.2.1. Methyl 1-formylindoline-3-carboxylate (10). 34 mg
(20%); Rf¼0.20 (Et2O/hexanes, 3:1); mp 84–85.58C; IR
(KBr) 1732, 1665, 1594, 1497, 1367, 1283, 1220,
1
1174 cm21; H NMR (300 MHz; d6-DMSO) 3.69 (s, 3H),
4.0–4.5 (m, 3H), 7.09 (m, 1H), 7.26 (m, 1H), 7.37 (d, J¼
7.8 Hz, 1H), 7.48 (d, J¼8.1 Hz, 0.7H, major isomer), 7.91
(d, J¼7.8 Hz, 0.3H, minor), 8.50 (s, 0.3H, minor), 9.04 (s,
0.7H, major); 13C NMR (75.45 MHz; d6-DMSO) 44.0, 44.5,
46.9, 48.9, 52.5, 110.2, 115.6, 123.7, 124.1, 125.3, 125.9,
128.5, 128.6, 128.8, 129.4, 140.8, 158.3, 160.0, 171.2,
171.3; MS (EI) 205 (Mþ, 60), 177 (8),145 (35), 118 (100),
91 (17); Anal. calcd for C11H11NO3: C, 64.38; H, 5.40; N,
6.83. Found: C, 64.45; H, 5.47; N, 6.74.
4.4. Cyclization of Baylis–Hillman adduct 6
The Baylis–Hillman adduct 6 (200 mg, 0.71 mmol) and Fp2
(27 mg, 0.08 mmol) were placed in a glass-lined, 15 mL
stainless steel Parr reaction vessel with dioxane (10 mL).
The vessel was flushed thrice with CO (fume hood) and
charged to 800 psi. The mixture was heated to 1508C while
stirring for 24 h. After cooling and venting of CO (fume
hood) the resulting dark brown solution was filtered to
remove insoluble material, concentrated, and then chro-
matographed on silica gel with a gradient elution of
Et2O/hexanes (1:5 to 9:1) giving the following compounds:
4.2.2. Methyl 1H-indole-3-carboxylate (7). 25 mg (17%);
Rf¼0.25 (Et2O/hexanes, 1:1); spectroscopically identical to
material purchased from Aldrich.
4.2.3. 3-Methylquinolin-2(1H)-one (8). 6 mg (4%); Rf¼
0.26 (Et2O/hexanes, 3:1); identical to literature compound.37
4.4.1. Methyl 5-formyl-6,7-dihydro-5H-[1,3]dioxolo[4,5-f]-
indole-7-carboxylate (16). 14 mg (8%); Rf¼0.25 (Et2O/
hexanes, 3:1); IR (KBr) 2973, 2919, 1730, 1669, 1483,
4.3. Cyclization of Baylis–Hillman adduct 5
1
The Baylis–Hillman adduct 5 (0.24 g, 0.89 mmol) and Fp2
1297, 1220, 1035 cm21; H NMR (300 MHz; CDCl3) 3.76